 SUZHOU, China and PALO ALTO, Calif., Nov. 02, 2021 GLOBE NEWSWIRE -- Gracell Biotechnologies Inc. NASDAQ: GRCL Gracell, a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming conferences: 